Skip to content

Finished goods at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$990K
Pultegroup logo
PultegroupPHM
$8.38B
Freeport-McMoRan Inc. logo
Freeport-McMoRan Inc.FCX
$3.04B-5.5%
GameStop logo
GameStopGME
$423.3M+0.5%
Albemarle logo
AlbemarleALB
$44.3M-57.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$24.68M

Other financials

Income statement

See full
Revenue$1.1B-4.0%
Gross profit$363.2M-5.8%
Operating income$180.3M-1.8%
Net income$127.7M-10.9%
EPS (diluted)$3.10-3.1%

Balance sheet

See full
Cash & equivalents$771.3M+250%
Total debt$2.9B+52.5%
Total equity$1.7B-23.7%
Total assets$6.0B+9.9%

Cash flow

See full
Operating cash flow-$44.7M-2,583%
CapEx$28.3M-2.4%
Free cash flow-$73.0M-168%

Valuation

See full
Market cap$14.61B-9.3%
Enterprise value$16.72B-5.7%
P/E20.1×+7.4×
P/S2.9×-0.3×

Profitability

See full
Gross margin35.6%-1.9pp
Operating margin20.1%-1.9pp
Net margin14.6%-10.7pp
FCF margin18.6%+3.4pp

Returns & leverage

See full
Return on equity38%-12.3pp
Debt / equity1.7×+0.9×
Current ratio3.4×+0.8×

Where this comes from

Reported directly by Carlisle Companies in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Carlisle Companies’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Carlisle Companies's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Carlisle Companies's finished goods?
Carlisle Companies (CSL) reported finished goods of $303.8M in Q1 2026.
How has Carlisle Companies's finished goods changed year-over-year?
Carlisle Companies's finished goods decreased by 10.9% year-over-year, from $341.1M to $303.8M.
What is the long-term trend for Carlisle Companies's finished goods?
Over 5 years (2020 to 2025), Carlisle Companies's finished goods has grown at a 3.4% compound annual growth rate (CAGR), from $225.8M to $266.5M.